Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal ketamine for easier peripheral venous access in children
IRCT20120613010017N7Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ketamine (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Success in venipuncture, Duration of venipuncture and 1 more. Started Apr 2018; status: completed.
02
Drugs
ketamine
Beyond the preview
Go deeper on IRCT20120613010017N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120613010017N7.